ORASURE TECHNOLOGIES, INC Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31)
ORASURE TECHNOLOGIES, INC (OSUR) reported Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) of $0 for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Expense Statement › Income Tax
us-gaap:TaxBenefitFromStockOptionsExercised1 · last filed 2013-05-09
- ORASURE TECHNOLOGIES, INC tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $0.00.
- ORASURE TECHNOLOGIES, INC tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $0.00.
- ORASURE TECHNOLOGIES, INC tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2012 was $0.00.
- ORASURE TECHNOLOGIES, INC tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2011 was $0.00.
- ORASURE TECHNOLOGIES, INC tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2010 was $0.00.
| Period end | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 3 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 6 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 9 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-03-31 | $0.00 10-Q · filed 2013-05-09 | $0.00 derived: sum of 2 quarters · filed 2013-05-09 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | $0.00 10-K · filed 2013-03-13 | ||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-09 | |||
| 2011-12-31 | $0.00 10-K · filed 2013-03-13 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |